Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

"It was just like talking to a friend about a really horrible time in life and how you find ways of getting through it," ...

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today ...

“Walking, swimming and yoga are great for your veins because they keep the blood moving,” he explained. “If you sit or stand ...

Preventing blood clots could be as simple as changing the wavelength of light exposure. Find out how this discovery could revolutionize thrombosis prevention.

Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

Studies reveal a connection between red light exposure and a reduced risk of blood clots, offering potential new insights for ...

Exposure to long-wavelength red light significantly reduced blood clot formation in both mice and human studies.

The global varicose vein treatment market is set to witness significant growth over the next decade, with its valuation ...

Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines ...

Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for the treatment of diabetic macular edema in October ...